Precision medicine in metastatic colorectal cancer: targeting KRAS G12C mutation

Transl Gastroenterol Hepatol. 2024 Sep 12:9:53. doi: 10.21037/tgh-24-28. eCollection 2024.

Author

Jorge Aparicio¹

Affiliation

¹ Department of Medical Oncology, La Fe University and Polytechnic Hospital, Valencia, Spain.

No abstract available

Keywords: KRAS G12C mutation; metastatic colorectal cancer (metastatic CRC); targeted therapies.

Publication types

Editorial
Comment